ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 152 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,054,000 | +68.2% | 838,078 | +0.5% | 0.00% | +50.0% |
| Q3 2019 | $3,004,000 | +40.9% | 834,197 | +4.9% | 0.00% | +100.0% |
| Q2 2019 | $2,132,000 | -7.1% | 795,239 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $2,295,000 | +95.5% | 775,024 | +5.0% | 0.00% | 0.0% |
| Q4 2018 | $1,174,000 | -57.8% | 737,853 | -2.5% | 0.00% | -50.0% |
| Q3 2018 | $2,785,000 | +49.4% | 756,631 | +14.9% | 0.00% | +100.0% |
| Q2 2018 | $1,864,000 | -28.3% | 658,344 | -6.1% | 0.00% | -50.0% |
| Q1 2018 | $2,601,000 | +64.4% | 700,848 | +27.6% | 0.00% | +100.0% |
| Q4 2017 | $1,582,000 | -33.0% | 549,189 | +4.5% | 0.00% | -50.0% |
| Q3 2017 | $2,360,000 | +12.4% | 525,612 | +14.9% | 0.00% | 0.0% |
| Q2 2017 | $2,100,000 | +9.7% | 457,341 | +0.6% | 0.00% | 0.0% |
| Q1 2017 | $1,914,000 | +8.0% | 454,491 | +6.0% | 0.00% | 0.0% |
| Q4 2016 | $1,772,000 | -50.4% | 428,841 | -2.7% | 0.00% | -50.0% |
| Q3 2016 | $3,571,000 | +9.1% | 440,860 | +5.1% | 0.00% | 0.0% |
| Q2 2016 | $3,272,000 | +8.3% | 419,370 | +7.2% | 0.00% | 0.0% |
| Q1 2016 | $3,020,000 | -26.9% | 391,106 | +2.1% | 0.00% | -33.3% |
| Q4 2015 | $4,134,000 | +67.0% | 383,095 | +7.0% | 0.01% | +50.0% |
| Q3 2015 | $2,475,000 | -16.9% | 358,093 | +6.6% | 0.00% | 0.0% |
| Q2 2015 | $2,977,000 | -7.4% | 335,931 | +3.1% | 0.00% | -20.0% |
| Q1 2015 | $3,214,000 | -1.4% | 325,920 | +22.5% | 0.01% | 0.0% |
| Q4 2014 | $3,260,000 | +24.7% | 266,103 | +1.6% | 0.01% | +25.0% |
| Q3 2014 | $2,615,000 | +47.7% | 261,961 | +12.0% | 0.00% | +33.3% |
| Q2 2014 | $1,771,000 | +149.4% | 233,886 | +8.4% | 0.00% | +200.0% |
| Q1 2014 | $710,000 | +1.9% | 215,686 | +2.9% | 0.00% | 0.0% |
| Q4 2013 | $697,000 | +24.7% | 209,686 | -0.5% | 0.00% | 0.0% |
| Q3 2013 | $559,000 | -64.6% | 210,745 | +11.4% | 0.00% | -75.0% |
| Q2 2013 | $1,581,000 | – | 189,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |